Bringing a wealth of investment experience, the fund manager has actively engaged in over 50 deals across technology and healthcare sectors, primarily focusing on North America and Europe. With a data-driven approach, they emphasize growth-stage investments, employing a thematic strategy that targets innovative companies poised for market disruption. Their track record includes notable exits that have significantly contributed to portfolio performance, showcasing a commitment to enhancing value through strategic partnerships. This operator-first mentality has enabled them to navigate complex market dynamics effectively.